170 related articles for article (PubMed ID: 37700359)
1. Dexamethasone suppression for
Kim K; Kim DK; Moon JH; Kim EH; Kim SH; Ku CR; Lee EJ
Cancer Imaging; 2023 Sep; 23(1):85. PubMed ID: 37700359
[TBL] [Abstract][Full Text] [Related]
2. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
[TBL] [Abstract][Full Text] [Related]
3. CRH stimulation improves
Boyle J; Patronas NJ; Smirniotopoulos J; Herscovitch P; Dieckman W; Millo C; Maric D; Chatain GP; Hayes CP; Benzo S; Scott G; Edwards N; Ray Chaudhury A; Lodish MB; Sharma S; Nieman LK; Stratakis CA; Lonser RR; Chittiboina P
Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
[TBL] [Abstract][Full Text] [Related]
4. Value of fluorine-18-fluorodeoxyglucose PET/CT in localizing the primary lesion in adrenocorticotropic hormone-dependent Cushing syndrome.
Zhou J; Ju H; Zhu L; Pan Y; Lv J; Zhang Y
Nucl Med Commun; 2019 May; 40(5):539-544. PubMed ID: 30973841
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions.
Seok H; Lee EY; Choe EY; Yang WI; Kim JY; Shin DY; Cho HJ; Kim TS; Yun MJ; Lee JD; Lee EJ; Lim SK; Rhee Y
Korean J Intern Med; 2013 Jan; 28(1):81-8. PubMed ID: 23346000
[TBL] [Abstract][Full Text] [Related]
6. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
al-Saadi N; Diederich S; Oelkers W
Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
8. [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome.
Markou A; Manning P; Kaya B; Datta SN; Bomanji JB; Conway GS
Eur J Endocrinol; 2005 Apr; 152(4):521-5. PubMed ID: 15817906
[TBL] [Abstract][Full Text] [Related]
9. Ectopic sphenoidal ACTH-secreting adenoma revealed by
Lurquin F; Constantinescu SM; Furnica RM; Duprez T; Raftopoulos C; Daoud L; Lammens M; Maiter D
BMC Endocr Disord; 2023 Feb; 23(1):43. PubMed ID: 36797716
[TBL] [Abstract][Full Text] [Related]
10. An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome Based on Low-Dose Dexamethasone Suppression Test.
Chen K; Chen S; Lu L; Zhu H; Zhang X; Tong A; Pan H; Wang R; Lu Z
Front Endocrinol (Lausanne); 2021; 12():720823. PubMed ID: 34539574
[TBL] [Abstract][Full Text] [Related]
11. Value of [18F] fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in diagnosis and localization of Cushing's disease.
Xin C; Rui-xue C; Hui P; Tao Y; Hui-Juan Z; Fang L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):107-10. PubMed ID: 21529433
[TBL] [Abstract][Full Text] [Related]
12. New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome.
Senanayake R; Gillett D; MacFarlane J; Van de Meulen M; Powlson A; Koulouri O; Casey R; Bashari W; Gurnell M
Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101513. PubMed ID: 34045044
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C
Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
[TBL] [Abstract][Full Text] [Related]
14. Assessment of bilateral inferior petrosal sinus sampling in the diagnosis and surgical treatment of the ACTH-dependent Cushing's syndrome: a comparison with other tests.
Shi X; Sun Q; Bian L; Zhao W; Shen J; Wang W; Ning G
Neuro Endocrinol Lett; 2011; 32(6):865-73. PubMed ID: 22286783
[TBL] [Abstract][Full Text] [Related]
15. Surgical outcomes and multidisciplinary management strategy of Cushing's disease: a single-center experience in China.
Zhang K; Shen M; Qiao N; Chen Z; He W; Ma Z; Shou X; Li S; Zhao Y; Pan L; Liu D; He M; Zhang Z; Li Y; Yao Z; Ye H; Wang Y
Neurosurg Focus; 2020 Jun; 48(6):E7. PubMed ID: 32480378
[TBL] [Abstract][Full Text] [Related]
16. Localization diagnosis of adrenocorticotrophic hormone-dependent Cushing's syndrome: two case reports and literature review.
Qiu Y; Zhao H; Pan H; Guo L; Du S; Qiu M; Wu C; Han J; Zhang X; Zhou Z; Li A; Li Q
Ann Palliat Med; 2022 Dec; 11(12):3804-3817. PubMed ID: 36636004
[TBL] [Abstract][Full Text] [Related]
17. Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study.
Jeong SY; Lee SW; Lee HJ; Kang S; Seo JH; Chun KA; Cho IH; Won KS; Zeon SK; Ahn BC; Lee J
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2334-43. PubMed ID: 20661556
[TBL] [Abstract][Full Text] [Related]
18. The role of integrated (18)F-FDG PET/CT in identification of ectopic ACTH secretion tumors.
Xu H; Zhang M; Zhai G; Zhang M; Ning G; Li B
Endocrine; 2009 Dec; 36(3):385-91. PubMed ID: 19806477
[TBL] [Abstract][Full Text] [Related]
19. [Bilateral inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome].
Belli S; Oneto A; Mendaro E
Rev Med Chil; 2007 Sep; 135(9):1095-102. PubMed ID: 18064362
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of the combined high-dose dexamethasone suppression test and desmopressin stimulation test in establishing the source of ACTH secretion in ACTH-dependent Cushing's syndrome.
Qiao J; Li J; Zhang W; Wang C; Li J; Jiang S; Tan H; Chen Y; Liu H; Cai B; Yu Y
Endocr J; 2021 Jul; 68(7):839-848. PubMed ID: 33790062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
